CORRECTED-UPDATE 1-Achillion partners with J&J to develop hep C drugs (May 19)

May 19 (Reuters) - Achillion Pharmaceuticals Inc said it will collaborate with Johnson & Johnson to develop and market its hepatitis C drugs including an oral regimen that could work on all genotypes and shorten treatment time.